Qube Research & Technologies (QRT)
PMVP icon

Qube Research & Technologies (QRT)’s PMV Pharmaceuticals PMVP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26,257
Closed -$39.1K – 3751
2024
Q3 		$39.1K Sell
26,257
-45,444
-63% -$70.2K ﹤0.01% 2894
2024
Q2 		$116K Buy
+71,701
New +$129K ﹤0.01% 2569
2023
Q4 		– Sell
-63,976
Closed -$393K – 4647
2023
Q3 		$393K Sell
63,976
-46,936
-42% -$323K ﹤0.01% 2128
2023
Q2 		$694K Sell
110,912
-138,676
-56% -$727K ﹤0.01% 1426
2023
Q1 		$1.19M Buy
249,588
+117,062
+88% +$824K 0.01% 1219
2022
Q4 		$1.15M Buy
132,526
+109,387
+473% +$1.17M 0.01% 1158
2022
Q3 		$275K Buy
+23,139
New +$334K ﹤0.01% 1662
2022
Q1 		– Sell
-18,168
Closed -$420K – 2866
2021
Q4 		$420K Buy
+18,168
New +$439K ﹤0.01% 1643

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PMVP Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of PMV Pharmaceuticals (PMVP) in Q4 2024, closing a stake of 26,257 shares — an estimated $39.1K sold.

Qube Research & Technologies (QRT) first reported a position in PMVP in Q4 2021 and held it in 8 quarters. The position peaked at $1.19M in Q1 2023. 70 funds tracked by Wall St. Rank hold PMVP as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining PMV Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 26,257 PMV Pharmaceuticals shares in Q4 2024, an estimated $39.1K.
  • Qube Research & Technologies (QRT) first reported a position in PMV Pharmaceuticals in Q4 2021 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s PMV Pharmaceuticals position peaked at $1.19M in Q1 2023.
  • 70 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.